A phase IB trial of 5-azacitidine (5AC) and suberoylanilide hydroxamic acid (SAHA) in patients with metastatic or locally recurrent nasopharyngeal carcinoma (NPC) and NK-T cell lymphoma.
Wen Son Hsieh
No relevant relationships to disclose
Eng Huat Tan
No relevant relationships to disclose
Wan-Teck Lim
No relevant relationships to disclose
Ross A. Soo
No relevant relationships to disclose
Anthony T. C. Chan
No relevant relationships to disclose
Edwin P. Hui
No relevant relationships to disclose
Soo-Chin Lee
No relevant relationships to disclose
John Soon Wah Low
No relevant relationships to disclose
Pei Li Lim
No relevant relationships to disclose
Thomas Kwok Seng Loh
No relevant relationships to disclose
Matthew M. Ames
No relevant relationships to disclose
Joel M. Reid
No relevant relationships to disclose
Paul Gerard Murray
No relevant relationships to disclose
Qian Tao
No relevant relationships to disclose
Boon C. Goh
No relevant relationships to disclose
Richard F. Ambinder
No relevant relationships to disclose